谭海宁山东大学主页平台管理系统--中文主页

更多

` 中文
- English

谭海宁

职称：教授
所在单位：国家糖工程技术研究中心

教师拼音名称：tanhaining
入职时间：2009-07-16
所在单位：国家糖工程技术研究中心
性别：男
在职信息：在职
是否在职：1

论文成果

[31] 谭海宁. Study on glyco-modification of endostatin-derived synthetic peptideendostatin2 (ES2) by soluble chitooligosaccharide. Carbohydrate Polymers, 154, 204, 2016.
[32] 王凤山 , 张新科 , 程艳娜 , 谭海宁 Tat PTD–endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops. Biochimica et Biophysica Acta, 1850, 1140, 2015.
[33] 王凤山 , 谭海宁 and 曹吉超. The preventive effects of heparin–superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice . MOL CELL BIOCHEM, 327, 219, 2009.
[34] 王凤山 , 程艳娜 and 谭海宁. Site-Specific Chemical Modification of Human Serum Albumin with Polyethylene Glycol Prolongs Half-life and Improves Intravascular Retention in Mice. Biol Pharm Bull, 35, 280, 2012.
[35] 谭海宁 , 王凤山 , 曹吉超 and 肖敏. Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin. . PHARMAZIE, 622, 2012.
[36] 谭海宁 , 王凤山 , 刘纯慧 and 曹吉超. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin. Biomedicine & Pharmacotherapy, 648, 2012.
[37] 谭海宁. Preparation of chitosan-based nanoparticles for delivery of low molecular weight heparin. J Biomed Nanotech, 7, 696, 2011.
[38] 王凤山 , 谭海宁 , 程艳娜 and 张新科. Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant. Carbohydrate Polymers, 446, 2014.
[39] 谭海宁. Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin. PHARMAZIE, 67, 622, 2012.
[40] 谭海宁. Enhanced Anti-Angiogenesis and Anti-Tumor Activity of Endostatin by Chemical Modification with Polyethylene Glycol and Low Molecular Weight Heparin. Biomedicine and Pharmcotherapy, 66, 648, 2012.
[41] 谭海宁. Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium Derived Factor Make Low molecular weight heparin-endostatin and Polyethylene glycol-endostatin Potential Candidates for Anti-angiogenesis Drug. Biological Pharmceutical Bulletin, 34, 545, 2011.
[42] 崔慧斐 , 刘纯慧 , 高德宗 , 王凤山 , 谭海宁 and 孙凤. Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: Glycol-split heparin-endostatin2 (GSHP-ES2). CARBOHYDRATE POLYMERS Journal, 207, 79, 2019.
[43] 王凤山 , 翟光喜 , 谭海宁 and 邢亮. Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulfate-ES2-AF nanoparticle conjugate. INTERNATIONAL JOURNAL OF NANOMEDICINE, 14, 2573, 2019.
[44] 王凤山 , 刘纯慧 , 谭海宁 and 曹吉超. Sulfation of a polysaccharide obtained from Phellinus ribis and potential biological activities of the sulfated derivatives. Carbohydrate Polymers, 77 , 370, 2009.
[45] 谭海宁. Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018.

共67条 3/5

首页上页下页尾页页

扫一扫用手机查看